Trademark Overview

---

On Friday, October 3, 2003, a trademark application was filed for HYTACAND with the United States Patent and Trademark Office. The USPTO has given the HYTACAND trademark a serial number of 78309038. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 14, 2012. This trademark is owned by AstraZeneca AB. The HYTACAND trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

General Information

---

Serial Number	78309038
Word Mark	HYTACAND
Filing Date	Friday, October 3, 2003
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, December 14, 2012
Registration Number	3089412
Registration Date	Tuesday, May 9, 2006
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, February 14, 2006

Trademark Statements

---

Goods and Services

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

Classification Information

---

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, December 14, 2012
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

---

Party Name	AstraZeneca AB
Party Type	30 - Original Registrant
Legal Entity Type	03 - Corporation
Address	Sodertalje SE-151 85 SE

---

Party Name	AstraZeneca AB
Party Type	20 - Owner at Publication
Legal Entity Type	03 - Corporation
Address	Sodertalje SE-151 85 SE

---

Party Name	AstraZeneca AB
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Sodertalje SE-151 85 SE

Trademark Events

---

Event Date	Event Description
Friday, December 14, 2012	CANCELLED SEC. 8 (6-YR)
Monday, July 23, 2007	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 9, 2006	REGISTERED-PRINCIPAL REGISTER
Tuesday, February 14, 2006	PUBLISHED FOR OPPOSITION
Wednesday, January 25, 2006	NOTICE OF PUBLICATION
Wednesday, January 4, 2006	AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
Monday, January 2, 2006	APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 2, 2006	PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, October 5, 2005	ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Wednesday, October 5, 2005	1(B) BASIS DELETED; NEW BASIS REQUESTED
Wednesday, September 7, 2005	NOTICE OF ALLOWANCE CANCELLED
Wednesday, October 5, 2005	PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, September 7, 2005	PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Wednesday, September 7, 2005	PAPER RECEIVED
Tuesday, March 29, 2005	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 4, 2005	PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2004	NOTICE OF PUBLICATION
Friday, October 29, 2004	LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 5, 2004	ASSIGNED TO LIE
Sunday, September 19, 2004	APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, September 19, 2004	AMENDMENT FROM APPLICANT ENTERED
Friday, August 20, 2004	CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, September 19, 2004	ASSIGNED TO LIE
Thursday, August 19, 2004	PAPER RECEIVED
Friday, August 20, 2004	PAPER RECEIVED
Friday, March 26, 2004	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 18, 2004	NON-FINAL ACTION MAILED
Wednesday, March 17, 2004	ASSIGNED TO EXAMINER

Related Keywords

---

hytacand diseases cardiovascular treatment preparations pharmaceutical